Figure 6.
Anti-spike IgG titers induced by a booster with SW-Vac 2µg formulation or commercial vaccine in mice. BALB/c mice (n = 8/group) were immunized on Days 0 and 14 with commercial Gam-COVID-Vac-rAd26/rAd5 vaccine plus a booster with SW-Vac formulation or Gam-COVID-Vac-rAd5 on Day 49 delivered intramuscularly (A). Serum collected on Day 14 after the last dose was analyzed by ELISA to determine the levels of W (B) or (C) S-specific IgG, IgG1 and IgG2a. Sera titers were obtained by plotting the OD 492 nm vs. log curve of the reciprocal of the dilution in the GraphPad Prism program. Titers are expressed as the inverse of the inflection point dilution of the curve. For statistical analysis, antibody titers were log-transformed and then analyzed by a one-way ANOVA with Bonferroni’s multiple comparisons test. For all treatments, the titers detected after the second dose were significantly different from those found after the first dose (p<0.0001).